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Abstract: Several bacterial cultures were isolated from sponge Halichondria sp., collected 
from the Gujarat coast of the Indo Pacific region. These bacterial cultures were fermented 
in  the  laboratory  (100  mL)  and  the  culture  filtrate  was  assayed  for  antibiotic  activity 
against 16 strains of clinical pathogens. Bacillus sp. (SAB1), the most potent of them and 
antagonistic to several clinically pathogenic Gram-positive, Gram-negative bacteria and 
the  fungus  Aspergillus  fumigatus  was  chosen  for  further  investigation.  Analysis  of the 
nucleotide  sequence  of  the  16S  rDNA  gene  of  Bacillus  sp.  SAB1  showed  a  strong 
similarity  (100%)  with  the  16S  rDNA  gene  of  Bacillus  licheniformis  HNL09.  The 
bioactive  compounds  produced  by  Bacillus  licheniformis  SAB1  (GenBank  accession 
number: DQ071568) were identified as indole (1), 3-phenylpropionic acid (2) and a dimer 
4,4′-oxybis[3-phenylpropionic acid] (3) on the basis of their Fourier Transform Infrared 
(FTIR),  Nuclear  Magnetic  Resonance  (NMR)  and  Electrospray  Ionization  Mass 
Spectrometer  (ESI-MS)  data.  There  is  a  single  reference  on  the  natural  occurrence  of 
compound 3 from the leaves of a terrestrial herb Aptenia cordifolia in the literature, so to 
the best of our knowledge, this is a first report of its natural occurrence from a marine 
source. The recovery of bacterial strains with antimicrobial activity suggests that marine-
invertebrates  remain  a  rich  source  for  the  isolation  of  culturable  isolates  capable  of 
producing novel bioactive secondary metabolites. 
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1. Introduction  
Sponges are the most primitive of multicelled animals and have existed for more than 800 million 
years [1]. They are known to produce secondary metabolites which play a decisive ecological role, 
protecting them against potential invaders, predators or other competitors [2]. Bacteria growing on the 
surface of sponges live in a highly competitive environment in which access to space and nutrients are 
limited  [3,4].  Secondary  metabolites  produced  by  sponge-associated  bacteria  far  exceed  those 
produced  by  planktonic  bacteria  [5–9].  Several  potentially  therapeutic  compounds  identified  in 
sponges  have  striking  similarities  to  metabolites  derived  from  their  associated  microorganisms  
[10–12]. Hence, sponge-associated bacteria become a highly potential source for the production of 
antibiotic compounds.  
The appearence of bacterial resistance to a number of antimicrobial agents is becoming a major health 
problem worldwide. Secondly, increasing use and misuse, of existing antibiotics in human, veterinary 
medicine  and  in  agriculture  has  further  aggravated  the  problem  [13].  Common  among  them  are 
methicillin-resistant  Staphylococcus  aureus  (MRSA),  penicillin-resistant  Streptococcus  pneumoniae, 
vancomycin-resistant Enterococcus and Mycobacterium tuberculosis. It is further stated that, about  
70 percent of the bacteria that cause infections in hospitals are resistant to at least one of the drugs 
most commonly used for treatment [13]. Hence, the need is now felt more than ever before to find new 
classes of antimicrobials to combat multi drug resistant (MDR) strains especially targeting marine 
sources for the purpose.  
The  aim  of  the  present  investigation  was  to  isolate  culturable  marine  bacteria  associated  with 
sponge Halichondria sp. and to determine which of these isolated bacteria produced potentially useful 
antimicrobial substances. Their activity was tested against clinical pathogens and multidrug resistant 
bacterial strains. The most potent culture was identified as Bacillus licheniformis SAB1, on the basis 
of nucleotide sequence analysis of 16S rDNA gene. Mass culture of Bacillus licheniformis SAB1 for 
chemical characterization led to the identification of three compounds of which two are known and the 
third one, which though known as metabolite of a terrestrial herb, Aptenia cordifolia, is being reported 
here for the first time from a marine bacterium.  
2. Results and Discussion  
It has  been  estimated  that  over 99%  of the marine sponge-associated  microbes  have  yet to  be 
cultured in the laboratory with bacteria isolated from the sponges containing diverse Bacillus species 
being one of the most divergent forms [14].  
Crude  extracts  of  marine  bacteria  isolated  from  the  surface  of  sponge  Halichondria  sp.  were 
subjected to antimicrobial (antibacterial and antifungal) screening against clinical pathogens. The list 
of pathogens used for primary screening is shown in Table 1. Bacterial cultures (SAB1, SAB6, and 
SAB14) showed activity. However, as SAB1 was the most active one, it was taken for further study.  Mar. Drugs 2010, 8                       
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Strain SAB1 formed circular, opaque, raised, smooth colonies on Zobell Marine Agar (ZMA), with 
entire margin, creamy white in color and colony forming units measuring 3–4mm in diameter. Based 
on the nucleotide homology and phylogenetic analysis, the marine bacterium (SAB1) was identified to 
be  Bacillus  licheniformis  (showed  100%  similarity  with  Bacillus  licheniformis  HNL09,  GenBank 
Accession No. EU373344). 
Table 1. List of clinical pathogens used for antibiotic screening. 
Sr. 
No. 
Isolate 
no.  
Nature  of 
pathogen 
Name of pathogen  Disease it causes 
1.  B1 
Bacterial 
pathogens 
Escherichia coli  Gastrointestinal infection 
2.  B2  Pseudomonas aeruginosa  Urinary tract infection 
3.  B3  Staphylococcus aureus  Skin infection  
4.  B4  Salmonella typhi  Typhoid 
5.  B5  Shigella flexineri  Gastrointestinal infection 
6.  B6  Klebsiella sp.  Urinary tract infection 
7.  B7  Vibrio cholerae  Cholera 
8.  F1 
Fungal 
pathogens 
Aspergillus fumigatus  Skin infection 
9.  F2  Rhodotorula sp.  Skin infection 
10.  F3  Candida albicans  Candidiasis 
11.  F4  Cryptococcus neoformans  Skin infection 
12.  F5  Aspergillus niger  Skin infection 
13.  D1 
Multi-
drug 
resistant 
bacteria 
Streptococcus pyogenes  Skin infection 
14.  D2  Acinetobacter sp.  Urinary tract infection 
15.  D3  Salmonella typhi  Typhoid 
16.  D4  Methicillin Resistant 
Staphylococcus aureus 
Skin infection 
 
Mass culture of B. licheniformis SAB1 for chemical characterization resulted in a fermentation 
medium possessing a very strong unpleasant odor and bioassay guided isolation of the crude methanol 
extract yielded three compounds. Table 2 shows the spectral details of these three compounds. 
Compound 1, with an intense fecal odor, has a molecular formula C8H7N as deduced from its 
pseudomolecular ion [M+H]
+ at m/z 118.054 in the electospray ionization mass spectrum (ESI-MS). 
The 
1H-NMR spectrum (Table 2) exhibited two doublets one centered at  7.64 (J = 7.5 Hz) and the 
second at  7.28 (J = 7.8 Hz) and a singlet at 6.55. A broad signal at  8.13 was assigned to –NH 
proton.  The 
13C  NMR  spectrum  showed  the  presence  of  intense  six  doublets  in  the  region  from  
 102.42 to  124.13 ppm and two quaternary carbons at   127.76 ppm and  135.69 ppm. The 
compound  was  confirmed  to  be  indole  by  comparing  the  NMR  spectrum  with  spectrum  3,121A,  
Vol III, of the Aldrich Library of 
13C and 
1H FT-NMR spectra (Edition 1). The IR spectrum indicated 
the presence of an -NH group at 3,402 cm
−1.  
N
H  
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Compound (2), a major metabolite from the crude extract of B. licheniformis SAB1 was identified 
as 3-phenylpropionic acid. The electrospray ionization mass spectrum (ESI-MS) showed the presence 
of a signal at m/z 189 due to [M+K]
+ and m/z 339 due to [2M+K]
+ indicating its molecular formula to 
be C9H10O2. The 
1H- and 
13C-NMR data (Table 2) showed signals in the region from  7.19 to  7.38 
for aromatic protons with the corresponding carbons as doublets at  126.38, 128.24 and 128.54. The 
singlet at 140.13 was attributed to the tetra substituted aromatic carbon and the signal at  179.45 was 
assigned to the carboxyl carbon. The signals due to methylenes   and  to carboxyl group were 
evident as two triplets in the 
1H-NMR spectra centered at  2.68 and  2.96 and the corresponding 
carbon signal appeared at  30.54 and  35.61, respectively. The carboxylic acid carbonyl was evident 
in  its  infrared  spectrum  at  1,712  cm
−1,  whereas  the  presence  of  signals  between  1,604  cm
−1  and  
1,496 cm
−1 was suggestive of aromaticity that was further confirmed by the presence of corresponding 
signal in its nuclear magnetic resonance (NMR) spectra. On the basis of the above spectral data the 
compound has been identified as 3-phenylpropionic acid which was also in good agreement with the 
spectral data given in Aldrich catalogue of NMR data.  
CH2 CH2 COOH
 
2 
Compound  3,  the  most  polar  of  the  three  showed  a  pseudomolecular  ion  peak  at  m/z  362.1  
[M+2Na+2H]
+ in the ESI-MS spectrum suggesting a molecular formula of C18H18O5. The 
1H- and  
13C-NMR data indicated a highly symmetric molecule with its 
1H-NMR data closely resembling that 
of compound 2, but the pattern of substitution in the aromatic ring, i.e., two doublets at  6.75 (d,  
J = 8.4 Hz) and  7.07 (d, J = 8.4Hz) was suggestive of para substitution in the ring. Eight aromatic 
protons were present as two ortho-coupled protons and eight methylene protons as two triplets in 
aliphatic region. The 
13C-NMR spectrum (Table 2) showed only seven carbon signals. The signal at  
 154.11 indicated that the one substituent in the ring could be a hydroxyl group. The DEPT spectrum 
showed  two  methylenes,  and  two  methines.  The  intense  signal  at  m/z  362.0607  [M+2Na+2H]
+, 
suggested that the molecule must be a symmetric dimer with an ether bridge in between. From this 
spectral data compound 3 was assigned to be 4,4′-oxybis[3-phenylpropionic acid]. 
CH2
O
CH2 COOH
CH2 CH2 COOH 
3 
The spectral data of compound 3 agree well with that of apteniol A, an oxyneolignan from the 
leaves of Aptenia cordifolia, a terrestrial perennial herb belonging to the family Aizoaceae, native to Mar. Drugs 2010, 8                       
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South Africa but now largely diffused throughout Europe [15]. There is no literature available to show 
that it was ever reported earlier from any marine source. Hence, the present study becomes the first 
report  of  this  compound  from  a  marine  bacterium  Bacillus  licheniformis  SAB1,  and  it  is  also  a  
first  report  of  its  antimicrobial  activity,  as  it  showed  significant  antifungal  activity  against  
Aspergillus fumigatus (7–10 mm zone) and moderate antibacterial activity against Vibrio cholerae and 
Salmonella  typhi.  Apteniol  A  was  tested  for  its  phytotoxicity  on  the  seeds  of  Lactuca  sativa  at 
concentrations  ranging  between  10
−4  and  10
−7 M  and  it  was  found  that  apteniol  A  reduced  root 
elongation by 40% when compared to the control.  
Antimicrobial activity of the crude extract, pure compounds, positive (standard antibiotics) and 
negative (solvent) controls are summarized in Table 3. The crude methanol extract of strain SAB1 
showed significant antibacterial activity against  Pseudomonas aeruginosa, with an inhibition zone 
between  7–10  mm,  moderate  (4–6  mm)  antibacterial  activity  against  Staphylococcus  aureus,  and 
antifungal activity against Aspergillus fumigatus. Mild inhibitory activity was exhibited by all the test 
strains  under  study,  except  E  coli,  Shigella  flexineri,  Klebsiella  sp.,  multi  drug  resistant  (MDR) 
Salmonella typhi and  fungal pathogen  Cryptococcus neoformans. Compound 1 showed significant 
antibiotic  activity  against  bacterial  pathogens:  methicillin  sensitive  Staphylococcus  aureus,  
Salmonella typhi, and fungal pathogen: Candida albicans (inhibition zone 7–10 mm each). Moderate 
activity was exhibited against Pseudomonas aeruginosa, methicillin resistant Staphylococcus aureus 
and  fungus  Rhodotorula  sp.  (4–6  mm).  Weak  activity  was  observed  against  MDR  Streptococcus 
pyogenes, MDR Acinetobacter sp. and Aspergillus niger (1–3 mm) respectively. Clinical pathogens 
Escherichia coli, Shigella flexineri, Klebsiella sp., Vibrio cholerae, Salmonella typhi and the fungal 
pathogen Aspergillus fumigatus and Cryptococcus neoformans were insensitive to indole. Compound 2 
(3-phenylpropionic acid) showed significant antifungal activity against Rhodotorula sp. (7–10 mm 
inhibition zone) and moderate antifungal activity against Candida albicans and Aspergillus niger (4–6 mm). 
On the other hand, only moderate antibacterial activity was shown against Pseudomonas aeruginosa, drug 
sensitive Staphylococcus aureus, Salmonella typhi, MDR-Streptococcus pyogenes, MDR-Acinetobacter 
sp.  and  methicillin  resistant  Staphylococcus  aureus.  The  remaining  pathogens  were  insensitive  to 
compound 2. Similar report on antifungal properties of this compound was reported by Mao et al. [16], 
who describe its antifungal activity, inhibiting growth of D. bryoniae, B. cinerea, Pestalotiopsis sp. 
and C. gloeosporioides. Narayana and co-workers [17] reported on its antimicrobial activity against 
different test microorganisms including bacteria (Pseudomonas aeruginosa, P. fluorescens, B. subtilis, 
Escherichia coli & Proteus vulgaris) and fungi (F. udum, Aspergillus flavus, Penicillium citrinum, 
Candida albicans & A. niger). Compound 3, 4,4′-oxybis[3-phenylpropionic acid], showed significant 
antifungal activity against Aspergillus fumigatus (7–10 mm zone) and moderate antibacterial activity 
against Vibrio cholerae and Salmonella typhi (Table 3).  
Although, the antibiotic activity of marine bacteria is well-known and has been demonstrated in a 
number of studies [18–21], the vast diversity of microorganisms in the marine niches [22], continue to 
yield many novel bioactive compounds. Hence, exploration of biotechnological potentials of microbes 
associated with invertebrates still remains a very important and untapped resource. Modification of 
culture  media  and  new  cultivation  methods  are  clearly  needed  for  better  exploration  of  the 
biotechnological potential of invertebrate-associated microbes.  
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Table 2. 
1H- and 
13C-NMR data of Compounds 1, 2 and 3. 
Compound 1: indole  Compound 2: 3-phenylpropionic acid  Compound 3: 4,4'-oxybis(3-phenylpropionic acid) 
Position 
1HNMR  
13CNMR  Position 
1HNMR  
13CNMR  Position 
1HNMR  
13CNMR 
1  8. 1 3 (b,s)  -  1  -  179.45  1,1'  -  132.46 
2  7. 6 4 (d, 7.5Hz)  124.13  2  2.96(t,7.5,7.8Hz)  35.61  2,6,2',6'  7.07(d, 8.4Hz)  115.43 
3  7. 2 8 (d, 7.8Hz)  121.89  3  2.68(t, 7.5,7.8Hz)  30.54  3,5,3',5'  6.75(d, 8.4Hz)  129.48 
4  6. 5 5 (s)  102.42  1'  -  140.13  4,4'  -   154.11 
5  7.09-7.23 (3H, m)  120.65  2',6'   7.19-7.38(5H,m)  128.54  7,7'  2.89(t, 7.5,7.8Hz)  29.88 
6    119.74  3',5'    128.24  8,8'  2.64(t, 7.5,7.8Hz)  34.49 
7    111.01  4'     126.38       
8    135.69             
9    127.76             
Table 3. Antibiotic activity of crude, and pure compounds (Comp 1- indole; Comp 2 –  
3-phenylpropionic  acid;  Comp  3-  4,4′-oxybis(3-phenylpropionic  acid)  isolated  from 
Bacillus licheniformis SAB1. 
No.  Pathogens used for study 
Crude Extract 
(100µg/disc) 
Comp 1 
(50µg/disc) 
Comp 2 
(50µg/disc) 
Comp 3 
(50µg/disc)  
STD Antibiotics 
(50µg/disc)  
Solvent 
Methanol 
B1  Escherichia coli  -  -  -  -  ++++  - 
B2  Pseudomonas aeruginosa  +++  ++  ++  -  +++++  - 
B3  Staphylococcus aureus  ++  +++  ++  -  +++  - 
B4  Salmonella typhi  +  +++  ++  ++  ++  - 
B5  Shigella flexineri  -  -  -  -  +++++  - 
B6  Klebsiella sp.  -  -  -  -  +++++  - 
B7  Vibrio cholerae  +  -  -  ++  +++++  - 
D1  Streptococcus pyogenes  +  +  ++  -  ++  - 
D2  Acinetobacter sp.  +  +  ++  -  -  - 
D3  Salmonella typhi  -  -  -  -  -  - 
D4  Methicillin Resistant S.aureus   +  ++  ++  -  ++  - 
F1  Aspergillus fumigatus  ++  -  -  +++  ++++  - 
F2  Rhodotorula sp.  +  ++  +++  -  -  - 
F3  Candida albicans  +  +++  ++  -  -  - 
F4  Aspergillus niger  +  +  ++  -  -  - 
F5  Cryptococcus neoformans   -  -  -  -  -  - 
 -  no  zone  of  growth  inhibition;  +  1-3mm  zone  of  inhibition;  ++  4-6mm  zone  of  inhibition;  +++  7-10mm  zone  of  inhibition;  
++++ 11-15mm zone of inhibition; +++++ 16-22mm zone of inhibition; Antibiotics: Streptomycin/Ketoconazole. 
3. Experimental Section  
3.1. Isolation of Bacteria Associated with Marine Sponge 
All  the  bacterial  strains  used  in  this  study  were  obtained  from  an  orange-colored  sponge, 
Halichondria sp. collected off Gujarat, West Coast of India, from a depth of 10 m by SCUBA diving. 
The sponge sample soon after collection was transferred to a sterile polyethylene bag and transported 
under frozen condition to the laboratory for the isolation of associated microbes. On reaching the Mar. Drugs 2010, 8                       
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laboratory, the invertebrate was thawed and cut aseptically into small pieces (2 ×  2 cm) using a sterile 
scalpel. The pieces were freed from adhering particles by vortexing twice for 20 seconds with 2 mL of 
sterile  seawater.  The  seawater  was  decanted  and  replaced  with  methanol,  which  was  once  again 
replaced with sterile seawater with continued vortexing between washings. Finally, samples in sterile 
seawater  were  homogenized  using  sterilized  mortar  and  pestle  in  a  Laminar  flow  hood.  The 
homogenate was serially diluted up to 10
−3 dilutions and then spread plated on Zobell Marine Agar 
(ZMA) plates which contained ketoconazole (100 μg/mL) as an antifungal agent. The plates were 
incubated at room temperature (28 ±  2 ° C) for 2 days till visual growth of culture was observed. Single 
bacterial colonies were isolated on the basis of distinct colony morphologies from the Zobell Marine 
Agar (ZMA) plates. Colonies were selected on the basis of uniqueness relative to other plates and ease 
to select single colonies. Isolates were maintained on ZMA agar slants at 4 ° C until use.  
3.2. Polymerase Chain Reaction 
Genomic  DNA  was  isolated  from  the  pure  SAB1  culture  pellet.  Using  consensus  primers,  the  
~1.5  kb  16S  rDNA  fragment  was  amplified  using  Taq  DNA  polymerase.  PCR  product  was  
bi-directionally  sequenced  using  primer  27f  (5′-AGAGTTTGATCCTGGCTCAG-3′),  paired  with 
1492r (5′-TACGGCTACCTTGTTACGACTT-3′) and an internal primer. Sequence data of the strain 
SAB1 generated in this reaction was aligned with the 16S rDNA sequence of other closely related 
Bacillus  species  retrieved  from  the  Gene  Bank  database  and  analyzed  for  finding  the  closest 
homologues for the microbes. After sequence alignment it was subjected to blast in NCBI database and 
then preceded with the alignment of the sequences in RDP database (GeNei; NCBI GenBank and RDP 
database). The alignment demonstrated that the strain was Bacillus licheniformis (GenBank accession 
number  DQ071568)  as  it  showed  100%  similarity  to  Bacillus  licheniformis  HNL09  (GenBank 
accession number EU373344). 
3.3. Cultivation of Bacterial Isolates for Screening 
The  isolated  bacteria  were  subcultured  on  Zobell  Marine  Agar  (ZMA)  plates  and  incubated  at  
28 ±  2 ° C for two days. A loopful of the bacterial culture from the plate was inoculated into 100 mL of 
Zobell Marine Broth (ZMB) prepared in sterile seawater (in duplicate) and incubated on a shaker at  
28  ±   2  ° C  for  48  h.  At  the  end  of  incubation  period,  the  fermentation  medium  was  individually 
centrifuged  at  7000×   g  for  20  minutes  to  separate  cell  mass  from  the  fermentation  medium.  The 
resulting medium, free from cells, was concentrated under vacuum and the methanol extract of the 
same was used for primary screening.  
3.4. Agar Disc Diffusion Assay  
Antibiotic screening of the crude extracts as well as the isolated pure compounds was performed by 
the disc diffusion assay as described earlier [23], against 16 clinical pathogens (listed in Table 1). The 
bacterial pathogens are numbered from B1 to B7, multi drug resistant (MDR) bacteria from D1 to D4 
and fungal pathogens from F1 to F5. Briefly, sterilized (121 ° C for 15 min) Whatman filter paper discs 
measuring 6 mm diameter were loaded with the sample of known concentration (100 µ g/disc for crude Mar. Drugs 2010, 8                       
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extracts, 50 µ g/disc for pure compounds). These discs impregnated with the test samples were placed 
on  Mueller  Hinton  Agar  plates  seeded  with  test  organisms.  Positive  and  negative  controls  using 
standard antibiotics (ketoconazole–antifungal; and streptomycin–antibacterial) and solvent discs were 
also run simultaneously. After 24 hours of incubation at 37 ° C, the diameter of each zone of growth 
inhibition was measured in millimeters to obtain a semi quantitative determination of the antibiotic 
nature of the extracts. The assay was carried out in duplicates.  
3.5. Cultivation of Sponge-Associated Bacterium (SAB1) for Secondary Metabolite Production 
Selected bacterial strain (SAB1) showing significant activity during primary screening was mass 
cultured  to  obtain  sufficient  material  for  chemical  characterization.  During  mass  culture,  8  litres  
(4 ×  2 L) of Zobell Marine Broth (ZMB) comprising of peptone (5 g/L), yeast extract (1 g/L), KH2PO4 
(0.1 g/L) dissolved in seawater was used. After introducing the inoculum of strain SAB1, the flasks 
were incubated for 72 h at room temperature (27 ±  2 ° C) on a shaker. At the end of the incubation 
period,  the  cells  were  separated  from  the  fermentation  medium  by  centrifuging  at  7000×   g  for  
20 minutes. The cell-free supernatant medium was concentrated to dryness in a lyophilizer at −80
 ° C.  
3.6. Extraction and Purification of Active Metabolites 
The crude methanolic extract of the lyophilized culture filtrate (190 mg) was fractionated on a silica 
gel (60–120 mesh) column with increasing concentrations of ethyl acetate (EA) in petroleum ether 
(PE) as eluant. Eluates collected in 10 mL fractions were pooled together based on their TLC profile 
using ethyl acetate-petroleum ether (15:85, v/v) as developing solvent system for compounds 1 and 2 
and ethyl acetate-petroleum ether (30:70, v/v) for compound 3. Spots were visualized by spraying with 
5% sulphuric acid in methanol followed by heating of the TLC plate in an oven for 2 minutes at  
110
 ° C. The compounds were eluted in the order of their polarity with compound 1 (49 mg, Rf = 0.36) 
being eluted first followed by compound 2 (60 mg, Rf = 0.2) and the most polar compound 3 (13 mg,  
Rf = 0.12) being eluted last.  
3.7. Analytical Methods/Instrumentation  
Lyophilization of sample was carried out in a Christ, ALPHA 2-4 LD plus instrument, NMR spectra 
were recorded at 23 ° C on a Bruker Avance AC-300 spectrometer, operating at 300 and 75 MHz for 
1H  and 
13C,  respectively,  using  tetramethylsilane  (TMS)  as  an  internal  standard.  Mass  data  was 
recorded on an Electrospray Ionization Tandem Mass Spectrometer (ESI/MS-MS) using a QSTAR XL 
System  mass  spectrometer  from  Applied  Biosystems.  Infra-red  spectra  were  recorded  on  a  
FTIR-Shimadzu  instrument.  TLC  was  performed  on  aluminium  sheets  pre-coated  with  silica  gel  
60 F254 (Merk KgaA, Damstadt, Germany, Cat No. 1.05554). All the solvents used were glass distilled. 
4. Conclusions  
The marine bacterium, Bacillus licheniformis SAB1, isolated from a Halichondria sp. sponge and 
identified  by  its  16S  rDNA  is  a  circular  Gram-positive  bacterium.  It  is  a  motile,  spore  forming 
facultative anaerobe belonging to B. subtilis group of the Bacilli. Primary screening of the cell free Mar. Drugs 2010, 8                       
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culture filtrate showed significant antimicrobial activity. Mass culture of B. licheniformis SAB1, for  
chemical characterization led to the isolation and identification of three compounds using 
1H- and 
13C  
Nuclear  Magnetic  Resonance  (NMR),  Electrospray  Ionization  Mass  Spectrometer  (ESI-MS)  and 
Fourier  Transform  Infrared  (FTIR)  spectrometers  as  indole  (1),  3-phenylpropionic  acid  (2)  and  
4,4′-oxybis[3-phenylpropionic acid] (3). Antibacterial and antifungal activities of these compounds are 
also  reported.  The  isolation  of  compound  3,  4,4′-oxybis[3-phenylpropionic  acid],  from  a  marine 
source, as well as its antimicrobial activity is reported here for the first time.  
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